Rosie joined the Dehns Brighton office in October 2020 after completing a Master’s degree (Distinction) at the University of Southampton. Her dissertation classified variants in congenital heart disease patients to investigate the presence of undiagnosed primary ciliopathies.
Rosie’s undergraduate degree, at the University of Cambridge, focused on Genetics in the final year, with a project involving CRISPR/Cas9 mutagenesis of Drosophila melanogaster lines. The project aimed to determine the effect of Plp mutagenesis on female fertility and egg chamber morphology.
Rosie qualified as a European Patent Attorney in 2024 and as a UK Chartered Patent Attorney in 2025. She works in the Dehns Biotechnology team.
Rosie has experience with a broad range of clients including Universities (and their associated spin out companies) and small- to medium-sized companies, and a few multinational corporations.
The majority of her work relates to the filing and prosecuting of patent applications in Europe and other jurisdictions worldwide (including Japan, Korea, China, the US, Canada, Australia, India, Vietnam and many South American countries), but she also has experience in patentability and freedom to operate analyses.
Rosie is involved in patent work in many areas of biotechnology and life sciences, including recombinant nucleic acid and protein products, diagnostic and prognostic assays/kits and methods, microbiology and probiotics, virology and vaccines, biomarkers, sequencing methods and sequencing library preparation, antibodies and antibody constructs, small molecule therapeutics, nucleic acid amplification, immunotherapies, cancer therapies, cosmetic compositions, nucleic acid nanostructures and gene editing methods/compositions.
Rosie featured in an episode of Dehns’ “The IP Podcast” where she discussed her experiences of studying STEM subjects at school and then entering a STEM profession as a woman – this podcast was part of Dehns’ contribution to “International Day of Women and Girls in STEM” in February 2023.